SHOX2 DNA Methylation is a Biomarker for the diagnosis of lung cancer based on bronchial aspirates

BACKGROUND: This study aimed to show that SHOX2 DNA methylation is a tumor marker in patients with suspected lung cancer by using bronchial fluid aspirated during bronchoscopy. Such a biomarker would be clinically valuable, especially when, following the first bronchoscopy, a final diagnosis cannot...

Descripción completa

Detalles Bibliográficos
Autores principales: Schmidt, Bernd, Liebenberg, Volker, Dietrich, Dimo, Schlegel, Thomas, Kneip, Christoph, Seegebarth, Anke, Flemming, Nadja, Seemann, Stefanie, Distler, Jürgen, Lewin, Jörn, Tetzner, Reimo, Weickmann, Sabine, Wille, Ulrike, Liloglou, Triantafillos, Raji, Olaide, Walshaw, Martin, Fleischhacker, Michael, Witt, Christian, Field, John K
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2988753/
https://www.ncbi.nlm.nih.gov/pubmed/21047392
http://dx.doi.org/10.1186/1471-2407-10-600

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2988753/
https://www.ncbi.nlm.nih.gov/pubmed/21047392
http://dx.doi.org/10.1186/1471-2407-10-600

Ejemplares similares